LatestPublic Hearing Scheduled for Bill Threatening Puerto Rico's Karst Zone
Cannabis

New York Appeals Court Reviews Cannabis Odor Search Cases From Before 2021 Legalization

Redacción
New York Appeals Court Reviews Cannabis Odor Search Cases From Before 2021 Legalization
Summary

New York's Court of Appeals heard arguments on September 16 regarding how cannabis legalization affects prior police search records. The legal question centers on whether new protections against searches based solely on cannabis odor should apply retroactively to vehicle searches conducted before legalization in 2021, even if the hearing occurs after the reform. This case has significant implications for individuals with prior cannabis-related charges and could affect the medical marijuana community's relationship with law enforcement. The decision may provide clarity on cannabis odor as probable cause in New York's evolving legal landscape.

Originally published on

Revista Cáñamo

By Redacción

Read full article(opens in new tab)

Fetched: September 23, 2026 at 10:01 AM

Related News

More news you might be interested in

View all
Spain's Health Ministry Identifies Four Synthetic Cannabinoids Seized in Madrid Prisons
Cannabis

Spain's Health Ministry Identifies Four Synthetic Cannabinoids Seized in Madrid Prisons

Spain's Ministry of Health issued an alert identifying four synthetic cannabinoids found on papers seized during ten interventions across Madrid prisons between November 2024 and April 2026. These substances, commonly called "papelitos" (small papers), represent a concerning trend of novel psychoactive substances circulating in correctional facilities. While the identification provides insights into specific synthetic cannabinoid variants being used, the alert does not quantify the extent of consumption or document the number of intoxication cases resulting from these substances. The findings highlight the need for continued surveillance and harm reduction strategies in prison settings, where access to synthetic cannabinoids poses public health and security risks.

5 hours ago
Revista Cáñamo
Highlandia Hemp THC Beverages: Choose Your Wellness Destination
Cannabis

Highlandia Hemp THC Beverages: Choose Your Wellness Destination

Highlandia offers innovative hemp THC beverages designed with destination-inspired flavors, doses, and formats to customize your cannabis experience. These products cater to different consumer preferences and wellness goals, allowing users to select options that match their desired effects. The beverage format provides an alternative consumption method to traditional cannabis products, offering precise dosing and convenient delivery. This product line demonstrates the growing market of cannabis-infused beverages that appeal to both wellness-conscious consumers and those seeking recreational experiences. Understanding proper dosing and product selection remains essential for safe and effective use.

6 hours ago
Cannabis Now
Strain Review: Grape Ape - A Banned Bud in Oregon's Regulatory Crackdown
Cannabis

Strain Review: Grape Ape - A Banned Bud in Oregon's Regulatory Crackdown

Oregon has banned 20 cannabis strain names, including Grape Ape, citing concerns that their names appeal to children. This regulatory action targets the marketing names only, not the plants themselves, as part of stricter oversight of the cannabis industry. Grape Ape, known for its indica-dominant genetics and grape-like aroma, has been used by patients seeking relief from various conditions. The strain ban reflects growing state efforts to prevent youth appeal and enforce responsible cannabis marketing practices. Understanding these regulatory changes helps consumers navigate legal options while maintaining access to therapeutic cannabis options.

6 hours ago
Cannabis Now
MJBizDaily
Cannabis

Canopy Growth Expands to UK Medical Cannabis Market with Distribution Agreement

Canadian cannabis producer Canopy Growth has entered the UK medical cannabis market through a distribution partnership with GROW Group, supplying four Canadian-grown flower strains to British patients. This strategic expansion strengthens Canopy's presence in the European medical cannabis sector, which is experiencing growing regulatory acceptance and patient access. The agreement demonstrates the increasing legitimacy of medical cannabis as a therapeutic option in established healthcare markets. UK physicians can now access Canopy's cultivated products for patients with qualifying medical conditions, contributing to the broader availability of regulated medical cannabis alternatives.

15 hours ago
MJBizDaily